Correction to: Expert statement on the ICU management of patients with thrombotic thrombocytopenic purpura.

Journal

Intensive care medicine
ISSN: 1432-1238
Titre abrégé: Intensive Care Med
Pays: United States
ID NLM: 7704851

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 23 1 2020
medline: 23 1 2020
entrez: 23 1 2020
Statut: ppublish

Résumé

The original version of this article unfortunately contained a mistake. The penultimate row of Table 4 shows INR > 1.5 which is incorrect. The correct figure is INR < 1.5. The authors apologize for the mistake. The correct table is given below.

Identifiants

DOI: 10.1007/s00134-019-05904-7 PMID: 31965263
pubmed: 31965263
doi: 10.1007/s00134-019-05904-7
pii: 10.1007/s00134-019-05904-7
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

570-571

Commentaires et corrections

Type : ErratumFor

Auteurs

Elie Azoulay (E)

Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France. elie.azoulay@aphp.fr.
ORCID: 0000-0002-8162-1508

Philippe R Bauer (PR)

Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN, USA.

Eric Mariotte (E)

Centre National Maladie rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, APHP, Saint-Louis Hospital and Paris University, Paris, France.

Lene Russell (L)

Department of Intensive Care, Copenhagen University Hospital, RigshospitaletCopenhagen Academy for Medical Simulation and Education, University of Copenhagen, and the Capital Region of Denmark, Copenhagen, Denmark.

Paul Knoebl (P)

Division of Hematology and Hemostasis Department of Medicine 1, Medical University of Vienna, Vienna, Austria.

Ignacio Martin-Loeches (I)

Department of Intensive Care Medicine, Multidisciplinary Intensive Care Research Organization (MICRO), St. James's Hospital, St James Street, Dublin 8, Ireland.

Frédéric Pène (F)

Centre National Maladie Rare des Microangiopathies Thrombotiques, Médecine Intensive et Réanimation, Cochin Hospital and Paris University, Paris, France.

Kathryn Puxty (K)

Department of Intensive Care, Glasgow Royal Infirmary, Glasgow, UK.

Pedro Povoa (P)

Polyvalent Intensive Care Unit, Hospital de São Francisco Xavier, Lisbon, Portugal.
NOVA Medical School, New University of Lisbon, Lisbon, Portugal.
Center for Clinical Epidemiology and Research, Unit of Clinical Epidemiology, Odense University Hospital Odense, Odense, Denmark.

Andreas Barratt-Due (A)

Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway.

Jose Garnacho-Montero (J)

Intensive Care Clinical Unit, Hospital Universitario Virgen Macarena, Seville, Spain.

Julia Wendon (J)

King's College Hospital, London, UK.

Laveena Munshi (L)

Interdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, ON, Canada.

Dominique Benoit (D)

Ghent University Hospital, Ghent, Belgium.

Michael von Bergwelt-Baildon (M)

Intensive Care in Hematologic and Oncologic Patients, Munich, Germany.
Medizinische Klinik und Poliklinik III, Klinikum der Universität München, Munich, Germany.

Marco Maggiorini (M)

Medical Intensive Care Unit, University Hospital of Zurich, Zurich, Switzerland.

Paul Coppo (P)

Centre National Maladie Rare des Microangiopathies Thrombotiques, Service d'Hématologie, Saint-Antoine Hospital and Paris University, Paris, France.

Spero Cataland (S)

Department of Medicine, Ohio State University, Columbus, OH, USA.

Agnès Veyradier (A)

Centre National Maladies Rares des Microangiopathies Thrombotiques, Service d'Hématologie, Lariboisière Hospital and Paris University, Paris, France.

Andry Van de Louw (A)

Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, PA, USA.

Classifications MeSH